CRER-0462C Neuraceq and Pylarify Radiopharmaceuticals
Awarded State & local contract opportunity Posted
- Solicitation number
- 2139043
- State
- New York
- Responses due
Opportunity facts
- Jurisdiction
- Point of contact
-
- Michael Assante michael.assante@stonybrook.edu (631) 444-4326
Updated .
About this opportunity
New York is requesting proposals for supply of Neuraceq and Pylarify radiopharmaceuticals under solicitation CRER-0462C, with proposals due October 6, 2026.
The procurement covers two radionuclide therapy agents: Neuraceq and Pylarify. These are specialty pharmaceutical products requiring manufacturing, handling, and distribution capabilities compliant with radiopharmaceutical regulations and likely subject to FDA oversight and state pharmacy licensure.
No contract value, term, incumbent, evaluation criteria, pre-bid meeting, questions deadline, or place of performance is identified in the available source material.
Opportunity text
Neuraceq and Pylarify radionuclide therapy agents
On GovTribe
Work this opportunity
- Track it in your pipeline
- Similar opportunities
- Ask GovTribe AI about this opportunity